Elsevier, The Lancet Regional Health - Western Pacific, Volume 37, August 2023
Background: Towards hepatitis C elimination among people who inject drugs (PWID), we assessed the effectiveness of a strategy consisting of a community-based respondent-driven sampling (RDS) as wide screening, a simplified and integrated hospital-based care, and prevention of reinfection supported by community-based organisations (CBO), in Hai Phong, Vietnam. Methods: Adults who injected heroin were enrolled in a RDS survey implemented in two CBO premises. Rapid HIV and HCV tests were done on site, and blood was taken for HCV RNA testing.
Elsevier,
The Lancet Regional Health - Europe, Volume 31, August 2023
This Comment supports SDGs 3 and 13 by highlighting the negative health impacts of climate change around the world and in Europe, and noting that populations most impacted by climate change tend to be the least responsible for contributing to it. The authors note that, like in the Global South, the most disadvantaged communities in Europe bear disproportionate burdens of negative health impacts of climate change, but that addressing this inequity is not currently an explicit goal of EU policies.
Elsevier,
The Lancet HIV, Volume 10, August 2023
This Article supports SDG 3 by showing that men who have sex with men (MSM) in Africa remain highly vulnerable to HIV acquisition and HIV-related mortality and morbidity, undermining the Global AIDS Strategy to end AIDS; realising the UNAIDS 95-95-95 targets and reducing disparities in HIV incidence requires urgent efforts to strengthen community-led prevention efforts.
Elsevier,
The Lancet Global Health, Volume 11, August 2023
This Article supports SDG 3 by showing that short-course tuberculosis preventive treatment is likely to be cost-effective (compared with no tuberculosis preventive treatment) for adult contacts in 15 countries and people living with HIV/AIDS in seven countries, even under conservative cost-effectiveness thresholds.
Elsevier,
The Lancet Regional Health - Europe, Volume 31, August 2023
This Article supports SDG 3 by focusing on pregnant and postpartum women with HIV and assessing the risk factors for adverse postpartum outcomes and examining which factors can be addressed to support breastfeeding in resource-rich settings.
Elsevier,
The Lancet Global Health, Volume 11, August 2023
This Article supports SDG 3 by examining cost-effectiveness of implementing the HITSystem, a web-based intervention designed to improve outcomes of infants exposed to HIV, in Kenya. The study finds that HITSystem is among the most cost-effective early infant diagnosis interventions reported to date; the the cost per infant exposed to HIV was US$31·38 and the incremental cost-effectiveness ratio for life-years saved was $82·72.
Elsevier,
The Lancet HIV, Volume 10, August 2023
This Article supports SDG 3 by highlighting the effectiveness of a new, multilevel service delivery model, including interventions at patient, provider, and clinic levels, that improves the virological outcomes of adolescents and young adults living with HIV, generalisable to the current treatment context in rural sub-Saharan Africa.
Elsevier,
The Lancet Microbe, Volume 4, August 2023
This Article supports SDG 3 by showing that international transmission of hepatitis C virus has occurred in recent years among men who have sex with men. This suggests that international coordination will be needed for microelimination in this population.
eClinicalMedicine, Volume 62, August 2023
Population-based surveys are expensive and time consuming. By determining state-level seropositivity using national testing service data and a Bayesian linear model, a map of HIV prevalence was generated across the whole of Nigeria. By identifying the areas in which HIV is most prevalent interventions can be targeted. This less resource intense Bayseian method allows for national monitoring of HIV prevalence.
Elsevier,
Engineering Applications of Artificial Intelligence, Volume 123, August 2023
Using brain tissue from donors with Alzheimer's disease, Anderson et al. identify new links between gene regulation and disease. These regulators could represent future clinical targets or disease markers for Alzheimer's diagnosis and treatment.
